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Abstract
As yet, genome-wide association studies (GWAS) have not added much to our understanding of the mechanisms of body
weight control and of the etiology of obesity. This shortcoming is widely attributed to the complexity of the issues. The
appeal of this explanation notwithstanding, we surmise that (i) an oversimpliﬁcation of the phenotype (namely by the use of
crude anthropometric traits) and (ii) a lack of sound concepts of body weight control and, thus, a lack of a clear research
focus have impeded better insights most. The idea of searching for polygenetic mechanisms underlying common forms of
obesity was born out of the impressive ﬁndings made for monogenetic forms of extreme obesity. In the case of common
obesity, however, observational studies on normal weight and overweight subjects never provided any strong evidence for a
tight internal control of body weight. In addition, empirical studies of weight changes in normal weight and overweight
subjects revealed an intra-individual variance that was similar to inter-individual variance suggesting the absence of tight
control of body weight. Not least, this lack of coerciveness is reﬂected by the present obesity epidemic. Finally, data on
detailed body composition highlight that body weight is too heterogeneous a phenotype to be controlled as a single entity. In
summary GWAS of obesity using crude anthropometric traits have likely been misled by popular heritability estimates that
may have been inﬂated in the ﬁrst place. To facilitate more robust and useful insights into the mechanisms of internal control
of human body weight and, consequently, the genetic basis of obesity, we argue in favor of a broad discussion between
scientists from the areas of integrative physiologic and of genomics. This discussion should aim at better conceived studies
employing biologically more meaningful phenotypes based on in depth body composition analysis. To advance the scientiﬁc
community—including the editors of our top journals—needs a re-launch of future GWAS of obesity.
Introduction
Genome-wide association studies (GWAS) of obesity have
been undertaken with the goal to identify human obesity
genes, that would in turn unravel the internal biological
causes of obesity and its associated co-morbidities. More-
over it was hoped that variants in these genes would also
allow an early identiﬁcation of susceptible individuals,
thereby facilitating personalized prevention and treatment of
obesity. Until today GWAS have identiﬁed 115 genetic loci
where sequence variation is statitistically associated with
the body mass index (BMI) at the population level [1].
Taken together however these associations explain only
2–3% of the variation in adult BMI. Moreover, long-
itudinally no signiﬁcant associations were found between
any lead single nucleotide polymorphisms (SNPs) from the
respective genome regions and weight changes suggesting
that these SNPs were not involved in body weight control
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[2]. These results and the low level of variance-explained
clearly call into question the clinical relevance of GWAS-
identiﬁed obesity genes.
GWAS of BMI alone are unlikely to provide much
information because BMI is merely a crude surrogate
measure of nutritional status. The concept of BMI dates
back to a period of underdeveloped scientiﬁc methodologies
and simplistic theories [3–5]. Some GWAS have tried to
overcome this inadequacy of the BMI by including other
commonly available anthropometric traits, such as waist
circumference (WC), hip circumference (HC), waist-to-hip-
(WC/HC-) ratio or height [6–8] and by analyzing these
traits in both univariate and multivariate fashion. There are
also some of the ﬁrst genetic studies of body composition
traits such as percentage FM, visceral adipose tissue (VAT)
and lean body mass (LBM; [9–12]) that identiﬁed some
novel genetic associations. However, the percent variance
explained by SNPs was still low (e.g., 0.16% for LBM,
[12]) and only few of the SNPs previously linked to BMI
were also found to be associated with body fatness [11].
The vast majority of the gene variants related to BMI and
obesity have neither established biological relevance nor
have they shown clinical relevance for obesity treatment
and prevention. They have also failed to explain genetic
heritability of obesity. The many BMI-associated SNP
alleles have relatively small effect size, both individually
and in total [13]. The fat mass (FM) and obesity related
(FTO) gene has the strongest genetic association with
obesity but even for the lead SNP in this gene, the median
per-allele effect on BMI is as low as 0.36 kg/m2 (for a
review see [14]). FTO was also found to associate both with
FM and LBM [14]. Moreover, while the impact of the FTO
gene seems to increase upon fat and protein intake, physical
activity has been shown to have the opposite effect [15].
Contrary to prior expectations GWAS have not yet
facilitated the identiﬁcation of individuals at risk of
becoming obese before they gained weight [13]. This rea-
lization suggests that genetic epidemiology may be inher-
ently unlikely to help to prevent obesity. Along the same
vein, because the functional link between BMI and asso-
cited SNPs is mostly unknown GWAS also did not unravel
biological control mechanisms of energy balance. In
response to this failing GWAS have been extended so as to
draw upon next generation sequencing efforts (e.g., inves-
tigating extremely obese subjects) and alternative study
designs (e.g., by involving other phenotypic traits like eat-
ing behavior, physical activity, and sedentary behavior) but
to little effect.
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Fig. 1 Sex-differences in the associations between BMI and fat mass
(a in kg, c in % body weight) and fat-free mass (b in kg, d in per-
centage body weight). Data are shown for 180 healthy adults at a mean
age of 42.7 ± 15.5 years (93 females and 87 males) and a mean BMI of
24.8 ± 2.99 kg/m2. Obese subjects were excluded from the analysis.
Signiﬁcant sex-differences in between the r-values were observed for
all regeressions shown (p < 0.05). In addition the slope of regression
lines for BMI and FFM were signiﬁcantly different between males and
females. For original data and more details of the protocol see ref. 17
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We surmise that the discouraging performance of GWAS
of obesity in the past is not only due to the frequently
invoked complexity of human body weight control. Instead,
it seems likely that the limited outcome of GWAS resulted
from an oversimpliﬁcation of both, the investigated phe-
notype and the concepts of its biological basis. In 1995, a
group of leading obesity experts recommended the use in
genetic studies of phenotypes based upon body composi-
tion, metabolism, and ingestive behavior [16]. However, up
to now none of this advice have been taken on board.
Instead the powerful tools of modern molecular biology
have been applied to crudes of measurements whereas
modern concepts of body composition and its control were
largely ignored. The following comments here are an
attempt to stimulate a new debate about how GWAS of
obesity can be improved—to the beneﬁts of both, future
scientiﬁc research and patient care.
Limitations of anthropometric traits as
targets of GWAS
BMI and the likes are not biological phenotypes
Anthropometric measures such as BMI and WC have prac-
tical value in clinical settings where they are used for risk
assessment and patient stratiﬁcation [3–5]. Physicians must
think and decide pragmatically and/or by convention (i.e.,
based on guidelines) which led them and not biology to deﬁne
BMI, WC, HC, and WC/HC-ratio. Taking these anthropo-
metric measures for biological entities has been misleading in
the ﬁrst place. The BMI for example is merely a numerical
score that is calculated from two other numerical measure-
ments, body weight and height, and therefore has no biolo-
gical meaning per se [3–5]. The same holds true for WC, HC,
and the WC/HC-ratio. Thus, GWAS for commonly available
anthropometric traits have been investigating the genetic basis
of a ‘non-biological’ phenotype. This is an odd practice;
strictly speaking, none of these simple anthropometric traits
can be used as quantitave outcomes in genomic research.
What is more, body weight and thus BMI are compo-
sites, they integrate body components such as FM, and fat-
free mass (FFM) as well as individual organs, tissues and
elements of differing masses and opposing course. Owing to
the consequent inter-individual variance and sex-
dependence of the associations between the BMI and dif-
ferent body components (e.g., FM and FFM, see Fig. 1),
BMI, cannot be a measure of body composition. In sum-
mary, BMI and similar anthropometric traits are not ‘bio-
logical’ phenotypes and may therefore be of little value in
genetic studies of obesity.
What is body shape?
In multivariate analyses of anthropometric traits one should
be aware that BMI, WC, and HC are highly correlated [17].
Recently, a GWAS of obesity, tried to address these inter-
dependencies by way of principal component analysis
Fig. 2 Three dimensional data interpolation of masses of skeletal
muscle (a), liver (b), brain (c), heart (d), kidneys (e), bone (f), whole
body adipose tissue (g), and visceral adipose tissue (h) as a function of
height and weight. For details of the calculations see ref. 16. Organ
and tissue masses were measured by whole body magnetic resonance
imaging (MRI) with a 1.5 T scanner (Magnetom Vision Siemens,
Erlangen, Germany). Cross-sectional organ and tissue areas were
determined manually using a segmentation software (SliceOmatic,
version 4.3, TomoVision Inc. Montreal, Canada). For further details of
the method and the study population see legend of Fig. 1
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(PCA) transforming multiple correlated traits into un-
correlated albeit abstract anthropometric parameters that
were claimed to deﬁne body shape [6]. Such indices of body
shape have been proposed before including BMI [18], body
adiposity index [19], a body shape index [20], body
roundness [21], waist/hip circumference [22, 23], height3/
waist circumference3 [24], waist circumference/height,
among others. These measures were not only found to be
correlated and overlapping [21, 24] but varied widely in
terms of their relationship to chronic diseases [23–27]. The
utility of PCA-derived body shape parameters still remains
to be determined, but it is evident that single numerical
measures are rather crude substitutes of something as com-
plex as body shape. We suspect that they will therefore be as
ineffective in biomedical research as classical anthropo-
metric traits and will be particularly inferior to the advanced
imaging-based phenotyping systems that are currently being
introduced in clinical and research settings [25].
Organ and tissue masses vs weight and height
Using three dimensional data interpolation of (i) weight,
height, and masses of organ and tissues and (ii) WC, HC,
and abdominal subcutaneous adipose tissue (aSAT) or VAT,
revealed considerable variations in terms of the underlying
statistical associations (Figs. 2 and 3; [17]). Different organ
and tissue masses scale differently as body weight and
height (e.g., VAT scales as body weight only whereas ske-
letal muscle scales as both height and weight; Fig. 2). The
same applies to the relationship between aSAT and VAT on
the one hand and WC and HC on the other (Fig. 3). These
differences highlight further the very limited value of simple
anthropometric traits as measures of body composition.
Similarly body shape appears to be rather loosely associated
with body composition too, in that it was found to improve
predictions of percentage body fat and VAT only slightly,
compared to BMI, WC, and HC [21].
In summary the use of anthropometric traits as surrogate
phenotypes in GWAS of obesity can be justiﬁed only by the
fact that these traits are easily available, inexpensive, and
non-invasive. From a scientiﬁc point of view however such
opportunistic arguments are not valid because of the ‘non-
biological’ nature of the traits in question implies that their
genetic analysis may have been inherently in vain.
What is body weight control about?
At present, GWAS are on genetics of the BMI or genetics of
obesity, i.e., a BMI > 30 kg/m2. This idea follows the
CBA
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Fig. 3 Three (ABC) and two (DEF) dimensional data interpolation of
masses of abdominal subcutaneous adipose tissue (a, d), visceral
adipose tissue (b, e), and the sum of abdominal subcutaneous adipose
tissue plus visceral adipose tissue (c, f) as a function of either waist and
hip circumferences or the ratio between waist to hip circumferences=
w/h-ratio. For further details of the method and the study population
see legend of Figs. 1 and 2
4
htt
p:/
/do
c.r
ero
.ch
historical heritability estimates of BMI obtained in either
twin or family or adoption studies (see below). From a
physiological point of view the concept of genetics of
BMI is not sound, because the genetic basis relates to
control of body weight rather than a ‘ﬁxed’ weight. From
a physiological point of view it does not make much sense
to look for GWAS of a static state unless one assumes that
the subjects are at their set point at the time of assessment.
Then, the random BMI may reﬂect the set point. However,
in population studies this idea is speculative. In addition
the concept of a set point is under debate (see below).
However if we assume that a set point exists it is likely
that random BMI data measured in population studies
vary around the individual set points and are affected by
recent weight changes. We feel that we should address the
genetic basis of control of body weight rather than the
genetics of the BMI.
The concept of body weight control
The concept of body weight control originated from
experimental observation of changes in appetite and weight
that resulted from hypothalamic lesions in rats (for over-
views see [28, 29]). The concept has remained virtually
unchanged until today. When it comes to understanding the
genetic basis of obesity however, we think that a more
sophisticated concept of body weight control is required.
More speciﬁcally, it has to be agreed what is controlled and
when this control occurs. Does body weight control mean
control (i) of the static masses of individual organs and
tissues (which add up to body weight) or (ii) of their
interrelationships or (iii) of their concerted changes when
body weight changes? Moreover distinct concepts apply to
body weight control related to growth, puberty, pregnancy,
and lactation.
A weight-change phenotype
A control of body weight can become apparent only in the
context of weight changes whereas a stable body weight
reﬂects adaptation say to lifestyle or environmental con-
ditions but not control [28]. This implies that future
GWAS of obesity should focus on what may called a
‘weight change phenotype’. Moreover, if any, then body
weight control is probably asymmetric [29, 30], so that it
must be distinguished between a ‘weight loss phenotype’
and a ‘weight gain phenotype’ even though the current
evidence suggests that the latter does not exist in humans
[30]. As yet only one study [2] has addressed the asso-
ciations between genetic variation and weight loss and
subsequent regain. Although some gene-lifestyle interac-
tions were found, the observed effect sizes were not
considered clinically relevant.
A body composition phenotype
Body weight comprises many different organs and tissue
masses. This underlying heterogeneity puts into question the
general idea that body weight as a single entity is under
stringent internal control. As far as GWAS are concerned it
appears more appropriate to deﬁne and use a ‘body com-
position phenotype’. However it would be too simplistic to
replace anthropometric traits such as BMI by single body
components such as FM or FFM or even speciﬁc organ and
tissue masses (such as skeletal muscle, brain, liver or VAT).
Although each component and its changes are related to
speciﬁc metabolic functions (e.g., FFM is closely related to
resting energy expenditure, REE; [17, 31]), no single body
composition trait or its change will strongly reﬂect metabolic
and physical functioning or the presence of cardio-metabolic
risk factors. Thus notwithstanding individual body compo-
nents are much more closely connected in biological pro-
cesses. Therefore these relationships are likely more useful
to address than anthropometric measures of obesity.
Correlation between different masses
Since the individual organs and tissue masses are strongly
correlated with one another and again differently correlated
with weight and height (except for brain;17), GWAS for
single body components are still unlikely to unravel much
of the genetic basis of obesity. Instead of assessing such
individual masses, GWAS on obesity should therefore
involve weight change-associated changes in body com-
position (i.e., the individual components and their rela-
tionships). This is because a change in one component of
the body (such as FM) is usually accompanied by a change
in other components (e.g., FFM). There is evidence that
control is about the association between masses and
volumes rather than about masses and volumes themselves
[32–37].
What is a suitable phenotype to be studied
in future GWAS for obesity?
Should we address changes in FM and FMM?
A high FM is not the cause of obesity but its consequence.
Therefore FFM is just as important for understanding obe-
sity (and its genetic basis) as FM. Moreover individual body
components including FM and FFM not only change dif-
ferently with weight changes but also impact differently
upon body weight-related changes in neuro-endocrinology,
metabolism, and cardio-metabolic risks [37].
Changes in FM and FFM with weight change impact
upon and are both reﬂected by the ‘p-ratio’ a parameter
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originally deﬁned to address a classical issue in nutritional
science [30] namely energy partitioning. The ‘p-ratio’
equals the fraction of energy mobilized during starvation or
energy gained during re-feeding in the form of protein, it
characterizes a ‘body component unit’ (i.e., body energy
and protein are closely inter-related; [36, 37]). During
starvation, both, initial FM and the protein compartment
that can be used as energy reserve jointly determine the
inter-individual variation in protein sparing and thus the ‘p-
ratio’ [33]. As yet, the genetic factors underlying this
variability and/or linking the two energy reserves together
are unknown so that the ‘p-ratio’ would provide a pheno-
type worthwhile to study in future GWAS of obesity.
Moreover, since body composition and its changes relate to
many other outcomes like energy expenditure (EE), energy
intake (EI), glucose tolerance, protein synthesis, physical
performance, and disease risks unraveling the genetic basis
of the ‘p-ratio’ would have far reaching consequences for a
more general understanding of metabolism-related disease
and health.
Energy partitioning with weight change is not only
related to the major body components, FM and FFM.
Functional ‘body composition units’ are also obvious for
other organ-tissue masses-inter-relationships, for example
with respect to associations between the liver mass and
VAT and/or skeletal muscle and bone mass [36, 37]. Each
body component has its own internal control. For example
total body water is regulated by hormones including anti-
diuretic hormone (ADH) and aldosterone and by kidney
function; body fat is inﬂuenced by the appetite control
system with leptin as a possible feedback control signal;
bone mineral content is regulated by osteocalcin, para-
thormone, and vitamin D; muscle mass is controlled by
anabolic factors such as insulin, insulin-like growth factor 1,
and testosterone. Since organ and tissue masses are also
interrelated by multiple cross-talks, the latter add to body
weight control as well. All these different ‘body component
units’ suggest that body weight is too heterogenous to be
regulated as a single entity.
Is an adipocentric view sufﬁcient?
During the last 20 years, research on body weight control
focused mainly on the feedback loop between FM and the
hypothalamic melanocortin neuronal system brought about
by leptin [29]. However, since FM accounts for only
10–40% of body weight, regulation of FM can only repre-
sent a similarly sized part of the body weight control.
Furthermore, a FM-related body weight control system
could hardly explain overeating in overweight subjects; by
contrast leptin is considered as a ‘starvation hormone’
counteracting a negative energy balance and weight loss
only [38]. Finally the temporal complexity of weight
changes (i.e., from minutes to hours dependent on acute
changes in plasma hormones and metabolites; from hours to
days dependent on hepatic glycogen stores; from days to
weeks and probably months dependent on fat stores and
body protein) argues in favor of the action of different
control systems too. Obviously this multifacetness cannot
be reﬂected appropriately by the ‘genetics’ of the BMI.
What is the evidence for a genetic control of
human body weight?
As yet 19 syndromic monogenetic obesities have been
elucidated [39]. These diseases have a beautiful simplicity
about a genetic mispelling resulting in obesity: A single
mutation results in obesity. The same data stimulated
research also into the polygenetic mechanisms of common
obesities by way of genomic screening of large population
samples. However faced with the many years of limited
success of GWAS of obesity it may be worthwhile recon-
sidering the underlying assumption that body weight is
genetically controlled.
Observational studies
In humans, long-term observational data on body weight are
frequently taken as indirect evidence that EI and EE are
strongly controlled. Indeed, studies of energy balance over
long periods of time (e.g., one year) suggest a tight control
of body weight with a daily imbalance between EI and EE
of only 10–20 kcal (see discussion in [40, 41]). However
long-term balance data cannot be extrapolated to make
inference about short-term control [42]. In fact, at the
individual level there is no correlation between EE on a
given day and EI of that day but a compensation may occur
later [42]. Obviously, the short-term matching of EI and EE
is poor.
Weight regain after weight loss (as is frequently seen
during the dietary treatment of obese patients) has been
taken as further evidence for the biological control (or a ‘set
point’) of body weight. However weight regain after weight
loss may be explained by physiological adaptation to restore
FM and FFM according to their partitioning characteristics
[35, 43–45] rather than by genetic signals. In particular, the
drive to eat for the restoration of body weight is determined
by feedback signaling of the losses in both, FM and FFM
[44]. An ‘active’ role of FFM deﬁcit in the control of EI [35,
45] is hence distinct from the ‘passive’ role of FFM in long-
term control of EI whereby energy demand of FFM, which
is the major determinant of REE, drives EI, hunger and self-
selected meal size [35, 45–47].
During periods of diet-induced weight loss, the decrease
in FM exceeds the decrease in FFM. Some 75% of weight
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loss is explained by FM compared to 25% explained by
FFM [48, 49]. After weight loss, the concomitant depletion
of FFM (i.e., loss of FFM relatively to pre-weight loss
values) contributes a strong drive to eat and hyperphagia,
which again leads to a re-gain of both, FM and FFM. This
has been described as ‘collateral fattening’ [45]. As a con-
sequence FFM and thus REE increase until a new equili-
brium between EI and EE and thus a stable body weight is
reached again. This idea derives from the results of the
classic Minnessota Starvation Study [32] and is also sup-
ported by the clinical observation, that the decrease of FFM
in weight-reduced overweight and obese patients was sig-
niﬁcantly associated with the regain of FM [50]. Taken
together, weight regain after weight loss is best explained
by energy balance effects rather than by a distinctive genetic
mechanism.
Heritability estimates
In humans, the idea of genetic control of body weight goes
back to rather high heritability estimates as obtained in twin
or other family studies (see [16, 51–53]). For example the
familial correlation in BMI was between 0.20 and 0.23 in
parent–offspring pairs, 0.20 to 0.34 in di-zygotic twins and
reached 0.58 to 0.88 in mono-zygotic twins [16, 51].
However heritability is a statistical concept, that draws upon
correlations between relatives to quantify how much of the
overall variability of a phenotype at the population level is
due to genetic variation. For example, a heritability of 0.5
for body weight would imply that half of the weight dif-
ference between two unrelated individuals is directly or
indirectly attributable to genetic differences between them.
This number puts research into the genetic basis of obesity
into perspective. Moreover, heritability does not give evi-
dence about the complexity of the genotype-phenotype
relationship in question. In any case, in view of the limited
outcome of past GWAS of BMI that cannot account for
existing heritability estimates for body weight, it has been
suggested that these heritability estimates were in fact
inﬂated [54]. However, even if the heritability were accu-
rate, they would still imply that GWAS have tried to explain
a rather limited proportion of the variance in body weight
only.
The use of weight changes and the associated changes in
body composition as targets of genomic research would
address yet another important aspect. Differences in the
response to overfeeding had been studied for periods of 22
and 100 days in mono-zygotic twins [55, 56]. and the inter-
pair variance in gains of either weight, FM and VAT was
found to be three to six times higher than the intra-pair
variance. This was taken as evidence for a ‘genotype-
overfeeding interaction’ that determines weight and fat gain
as well as fat distribution. The response to negative energy
balance (i.e., with underfeeding and after an exercise pro-
gram for periods of 22 and 100 days; [57, 58]) was also
investigated and at least under the long-term protocol [57],
the intra-pair variances in weight, FM and VAT reductions
were lower than the inter-pair variances suggesting a
‘genotype-underfeeding interaction’ as well. However,
these data have to be seen together with the intra-individual
variances in body weight changes, which have not been
taken into account in the studies cited [55–58].
Intra-individual and inter-individual variances in
changes of body weight
Up to now the intra- or within individual variances of
changes in body weight (and body composition) in response
to controlled under-feeding and over-feeding have not been
systematically studied. Variance is a mathematical property.
If the intra-individual variance (intra-CV) in changes in
body weight (or in masses of organs and tissues) is high,
inter-personal variance (inter-CV) in these outcomes is
difﬁcult to relate to biological factors. In a series of con-
trolled ﬁve week under-feeding and over-feeding studies of
young healthy men [59] the observed between-one-week-
run-differences in changes in body weight, FFM and FM
were within the order of the inter-CV. Within each indivi-
dual there were considerable day-to-day-variances in weight
changes (and also changes in FFM and FM) varying
between 26 and 88%. The high intra-individual day-to-day-
variances in body weight, FFM and FM suggest that at least
within short-term there is no tight biological control of body
weight. Within individuals, the huge day-to-day-variance in
body weight also questions a randomly measured body
weight as a sufﬁciently stable phenotype for use in genetic
epidemiological studies. Obviously, habitual body weight
(which is addressed in GWAS) cannot be assessed with
conﬁdence.
Weighing the evidence
The idea of a biological control of body weight in normal
weight and overweight humans originated mainly from
observational data and heritability estimates. In view of
(i) the variance in body weight changes observed in repeated
measurements and (ii) the high intra-individual day-to-day-
variances in weight loss and weight gain however a strict
internal control of over-feeding and underfeeding-related
changes in body weight and/or body composition seems
elusive at least for short-term changes. Since carefully
controlled long-term experiment (e.g., over one year) cannot
be done in humans deﬁnite clariﬁcation of this issue will be
difﬁcult. It is possible that in ‘modern’ humans, living an
abundant life, the biological control of body weight and the
proposed metabolic susceptibility to weight gain are
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obscured by strong environmental and societal driving for-
ces. Instead, high energy supply and a sedentary lifestyle are
the major drivers of body weight (e.g., in children and
adolescents, see [60, 61]). This view suggests a passive
adaptation rather than an active control of body weight [28]
which varies according to individual partitioning character-
istics (mainly due to FM and the FM-FFM-ratio at baseline;
[43, 45]) explaining most of the inter-individual variance in
weight changes (see above).
The ‘set point’ paradigm revisited
‘Set’ and/or ‘settling’
Current research into the genetic basis of obesity follows the
idea that human body weight itself is under strong internal
control. This view is in line with the so-called ‘set point’-
theory invoking a feedback system draws total body weight
to a constant ‘body-inherent’ weight. To this end the system
would actively adjust EI and/or EE in proportion to the
difference between the current body weight and the ‘set
point’ weight. The theory originated from animal studies
but has been questioned repeatedly in humans and a passive
feedback relationship has been alternatively proposed
between EI and the body size needed to change EE such
that a new energy balance is reached (i.e., the ‘settling
point’; [28, 41, 62]).
EI and/or EE
Most of current research into the regulation of energy bal-
ance and body weight focuses on EI [63]. EI supposedly
meets both energy and reward needs. Data from observa-
tional studies suggested that at least in humans living in
highly developed countries the biological control of EI to
meet energy needs is loose rather than tight [35, 64, 65].
Not least the obesity epidemic itself adds to the notion that
environmental and social characteristics (e.g., high food
supply, social inequalities in health) rather than biology
per se are major drivers of EI (e.g., [60, 61]). Compared to
EI, EE seems to be controlled within more narrow margins
because it is a vital characteristic and oxygen consumption
is a matter of survival [64]. Then control of body weight is
more about control of EE.
A ‘dual intervention point model’ of EE
Any increase or a decrease in body weight suggests that EI
has exceeded or fallen below some speciﬁc margin of EE.
Accordingly the ‘dual intervention point model’ of body
weight control [38, 41] can be replaced by a ‘dual inter-
vention point model’ of control of EE [64]. Then, the ‘upper
intervention point’ of EE reﬂects mitochondrial capacity
(sum of mitochondria in the body and their functional state)
whereas the ‘lower intervention point’ of EE reﬂects
metabolic adaptation to minimize energy needs during
caloric restriction [30, 59, 64]. The two intervention points
of EE and/or the distance between the two points are sug-
gested to be under biological control [64].
Teleologically, adaptation to energy deﬁcit (i.e., the
‘lower intervention point’) is about sparing body energy
and concomitantly meeting the basal energy needs of the
brain [30, 64]. By contrast, the ‘upper intervention point’
may be related to the protection of mitochondria them-
selves (e.g., limiting the production of reactive oxygen
species in response to overfeeding). Following this model
the focus of GWAS of BMI (and obesity) is shifted to the
two separate EE intervention points and/or the distance
between the two boundaries. In practice, the body weight-
(or FFM-) REE association and, thus, the residuals of the
measured REE on FFM (taking age, sex, and FM as
covariates) reﬂect the respective phenotype. From a phy-
siological point of view, this metabolic phenotype is fol-
lowed during controlled periods of over-feeding and
underfeeding.
The case of epigenome-wide association
studies
DNA methylation regulates the molecular phenotype in
response to for example high fat intake, physical activity,
and obesity [66]. Alterations in DNA methylation were seen
for some candidate genes for obesity such as FTO in adi-
pose tissue [67]. However epigenome-wide association
studies revealed that these changes are a consequence rather
than a cause of obesity: Levels of DNA methylation in
blood were shown to be associated with metabolic dis-
turbances and to modify the risk of type 2 diabetes mellitus
which was independent of BMI and WC [67].
To put these data into a context it is worthwhile
remembering that the association of BMI, WC, and/or FM
with cardio-metabolic traits are at best moderate (e.g., see
data in [68]). In cross-sectional studies, the respective cor-
relation coefﬁcients rarely exceeded 0.4, and the strongest
associations were observed with a biomarker of insulin
resistance (i.e., the HOMA index). A high correlation
coefﬁcient was observed when comparing liver fat and
insulin resistance (up to r= 0.80; 68). This ﬁnding is in line
with previous evidence showing that liver fat is closely
linked to metabolic complications of obesity [68–70]. Since
neither BMI nor WC nor FM nor VAT are correlated with
liver fat [71], the data argue again in favor of a detailed and
functional body composition analysis rather than involve-
ment single anthropometric and/or body component traits.
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Appreciation of a hypothesis-free approach
GWAS are hypothesis-free and, hence, represent a heuristic
approach to scientiﬁc research. In principle, any positive
GWAS result (i.e., even weak effects) may be biologically
meaningful and, therefore, worthwhile publishing. How-
ever, studies of genotype-phenotype relationships merely
reveal statistical associations that do not necessarily imply
causality. Furthermore, GWAS are not primarily focused
upon the meaning of results (which may only become
apparent in years to come, if ever) but operationally conﬁne
themselves to adding to the “approximately true description
of reality” [72]. This may be a reasonable justiﬁcation for
undertaking GWAS in the ﬁrst place but, because obesity is
a complex phenotype [73], collecting a virtually unlimited
number of measurements just for the sake of technical
feasibility is unlikely to add much to our understanding of
its complexity.
Hypothesis-driven research may be a more suitable
strategy to study obesity and, indeed, has been regarded
superior to hypothesis-free GWAS in this regard before. As
yet, however, the hypothetico-deductive strategies also have
failed to disentangle the complexity of obesity. In the end,
this is not surprising because complex problems rarely have
single solutions. In our view, it is therefore advisable to
accept and combine both research approaches. In so doing,
however, we strongly advocate the use of other, more
advanced phenotypes than, say BMI or body shape. The
latter lack biological relevance and should therefore be
replaced by more plausible phenotypes, based upon func-
tional body composition.
Conclusions
GWAS published so far have not added much to our
understanding of the proposed genetics of human obesity.
This is mainly due to the facts that (i) obesity, when deﬁned
by BMI, is not a workable phenotype and (ii) GWAS of
anthropometric traits lack a sound concept of body weight
control. It is also possible that at least in normal weight and
overweight humans tight control of body weight does not
exist which is reﬂected by the high intra-individual variance
in weight change raising doubt about a widely hold idea that
“a genetic basis of obesity and body composition is well
established” [65].
The unbroken optimism of genomics research sometimes
leaves us with the feeling that all molecular biology pro-
blems have already been solved or will at least going to be
solved soon. However, GWAS of obesity highlight the fact
that this is far from the truth. We surmise that a compre-
hensive, systems-oriented approach will be required to
advance obesity research that puts genetic variation into the
wider biological context including metabolic pathways,
protein–protein interactions and gene-regulatory networks.
In any case, future GWAS undoubtedly must draw more
heavily upon biologically-determined hypotheses about
their target genotype-phenotype relationships. To do that a
‘Phenome-Wide Association Study’ (PheWAS or Reverse
GWAS) using a ‘weight change phenotype’ as outcome is a
promising strategy.
Solid scientiﬁc research into the genetic basis of obesity
must no longer work in isolation from other disciplines.
Instead, GWAS should look more closely at the achieve-
ments of physiological research on obesity which at least at
present suggest a possibility that GWAS of obesity went
wrong in the past. It is never too late to do the right thing
even if, for the time being, the loaf has been hardly more
than none. We recommend a re-launch of future well con-
ceived GWAS of obesity.
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